vs

Side-by-side financial comparison of Outset Medical, Inc. (OM) and Ouster, Inc. (OUST). Click either name above to swap in a different company.

Ouster, Inc. is the larger business by last-quarter revenue ($48.6M vs $28.9M, roughly 1.7× Outset Medical, Inc.). Ouster, Inc. runs the higher net margin — 8.2% vs -67.5%, a 75.7% gap on every dollar of revenue. On growth, Ouster, Inc. posted the faster year-over-year revenue change (48.9% vs -2.0%). Over the past eight quarters, Ouster, Inc.'s revenue compounded faster (34.2% CAGR vs 1.2%).

Outset Medical, Inc. is a medical technology company focused on developing and commercializing innovative dialysis solutions for patients living with kidney disease. Its flagship Tablo Hemodialysis System supports use in acute care facilities, outpatient clinics, and home settings, serving healthcare providers and patients across the U.S. and select international markets.

Ouster, Inc. is an American lidar technology company headquartered in San Francisco, California. It builds high-resolution, digital 3D lidar sensors for use in autonomous vehicles, industrial, robotics, drones, mapping, defense, and security systems.

OM vs OUST — Head-to-Head

Bigger by revenue
OUST
OUST
1.7× larger
OUST
$48.6M
$28.9M
OM
Growing faster (revenue YoY)
OUST
OUST
+50.9% gap
OUST
48.9%
-2.0%
OM
Higher net margin
OUST
OUST
75.7% more per $
OUST
8.2%
-67.5%
OM
Faster 2-yr revenue CAGR
OUST
OUST
Annualised
OUST
34.2%
1.2%
OM

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
OM
OM
OUST
OUST
Revenue
$28.9M
$48.6M
Net Profit
$-19.5M
$4.0M
Gross Margin
42.4%
42.9%
Operating Margin
-61.1%
17.6%
Net Margin
-67.5%
8.2%
Revenue YoY
-2.0%
48.9%
Net Profit YoY
24.0%
EPS (diluted)
$0.33
$0.06

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OM
OM
OUST
OUST
Q1 26
$48.6M
Q4 25
$28.9M
$62.2M
Q3 25
$29.4M
$39.5M
Q2 25
$31.4M
$35.0M
Q1 25
$29.8M
$32.6M
Q4 24
$29.5M
$30.1M
Q3 24
$28.7M
$28.1M
Q2 24
$27.4M
$27.0M
Net Profit
OM
OM
OUST
OUST
Q1 26
$4.0M
Q4 25
$-19.5M
Q3 25
$-17.8M
$-21.7M
Q2 25
$-18.5M
$-20.6M
Q1 25
$-25.8M
$-22.0M
Q4 24
$-25.6M
Q3 24
$-27.9M
$-25.6M
Q2 24
$-34.5M
$-23.9M
Gross Margin
OM
OM
OUST
OUST
Q1 26
42.9%
Q4 25
42.4%
60.2%
Q3 25
39.4%
42.1%
Q2 25
37.8%
45.2%
Q1 25
37.2%
41.3%
Q4 24
36.5%
43.8%
Q3 24
34.3%
38.3%
Q2 24
35.7%
33.7%
Operating Margin
OM
OM
OUST
OUST
Q1 26
17.6%
Q4 25
-61.1%
1.5%
Q3 25
-53.7%
-61.4%
Q2 25
-53.7%
-76.5%
Q1 25
-55.1%
-73.0%
Q4 24
-74.2%
-85.1%
Q3 24
-83.2%
-98.0%
Q2 24
-112.3%
-93.6%
Net Margin
OM
OM
OUST
OUST
Q1 26
8.2%
Q4 25
-67.5%
Q3 25
-60.6%
-55.0%
Q2 25
-59.0%
-58.8%
Q1 25
-86.7%
-67.5%
Q4 24
-87.0%
Q3 24
-97.5%
-91.1%
Q2 24
-125.8%
-88.4%
EPS (diluted)
OM
OM
OUST
OUST
Q1 26
$0.06
Q4 25
$0.33
$0.10
Q3 25
$-1.00
$-0.37
Q2 25
$-1.04
$-0.38
Q1 25
$-3.66
$-0.42
Q4 24
$-7.21
$-0.46
Q3 24
$-8.02
$-0.54
Q2 24
$-9.96
$-0.53

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OM
OM
OUST
OUST
Cash + ST InvestmentsLiquidity on hand
$168.9M
$173.1M
Total DebtLower is stronger
$96.2M
Stockholders' EquityBook value
$127.0M
$275.6M
Total Assets
$264.5M
$381.5M
Debt / EquityLower = less leverage
0.76×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OM
OM
OUST
OUST
Q1 26
$173.1M
Q4 25
$168.9M
$208.6M
Q3 25
$178.6M
$244.5M
Q2 25
$184.1M
$226.5M
Q1 25
$189.0M
$168.2M
Q4 24
$158.7M
$172.0M
Q3 24
$175.6M
$151.4M
Q2 24
$194.8M
$184.2M
Total Debt
OM
OM
OUST
OUST
Q1 26
Q4 25
$96.2M
Q3 25
Q2 25
Q1 25
Q4 24
$197.4M
Q3 24
Q2 24
Stockholders' Equity
OM
OM
OUST
OUST
Q1 26
$275.6M
Q4 25
$127.0M
$261.7M
Q3 25
$142.4M
$247.4M
Q2 25
$154.8M
$221.0M
Q1 25
$169.9M
$167.9M
Q4 24
$26.8M
$180.9M
Q3 24
$47.8M
$171.7M
Q2 24
$68.6M
$170.6M
Total Assets
OM
OM
OUST
OUST
Q1 26
$381.5M
Q4 25
$264.5M
$349.5M
Q3 25
$277.3M
$353.8M
Q2 25
$288.8M
$321.8M
Q1 25
$301.2M
$268.6M
Q4 24
$275.8M
$276.1M
Q3 24
$292.9M
$255.2M
Q2 24
$314.5M
$309.9M
Debt / Equity
OM
OM
OUST
OUST
Q1 26
Q4 25
0.76×
Q3 25
Q2 25
Q1 25
Q4 24
7.36×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OM
OM
OUST
OUST
Operating Cash FlowLast quarter
$-9.5M
Free Cash FlowOCF − Capex
$-9.7M
FCF MarginFCF / Revenue
-33.7%
Capex IntensityCapex / Revenue
0.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-47.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OM
OM
OUST
OUST
Q1 26
Q4 25
$-9.5M
$-15.4M
Q3 25
$-6.3M
$-18.3M
Q2 25
$-4.8M
$-1.3M
Q1 25
$-25.7M
$-4.9M
Q4 24
$-16.5M
$-2.6M
Q3 24
$-20.6M
$-3.8M
Q2 24
$-33.3M
$-21.6M
Free Cash Flow
OM
OM
OUST
OUST
Q1 26
Q4 25
$-9.7M
$-37.2M
Q3 25
$-6.5M
$-20.0M
Q2 25
$-5.1M
$-2.2M
Q1 25
$-25.8M
$-5.4M
Q4 24
$-16.5M
$-4.0M
Q3 24
$-21.0M
$-4.3M
Q2 24
$-33.5M
$-22.0M
FCF Margin
OM
OM
OUST
OUST
Q1 26
Q4 25
-33.7%
-59.8%
Q3 25
-22.0%
-50.7%
Q2 25
-16.3%
-6.3%
Q1 25
-86.7%
-16.6%
Q4 24
-56.1%
-13.3%
Q3 24
-73.1%
-15.4%
Q2 24
-122.2%
-81.5%
Capex Intensity
OM
OM
OUST
OUST
Q1 26
Q4 25
0.8%
35.0%
Q3 25
0.5%
4.3%
Q2 25
0.9%
2.5%
Q1 25
0.4%
1.7%
Q4 24
0.1%
4.8%
Q3 24
1.4%
2.0%
Q2 24
0.4%
1.3%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

OM
OM

Consumables Product$13.5M47%
Service And Other Revenue$9.0M31%
Consoles Product$6.4M22%

OUST
OUST

Product revenue$48.2M99%
Royalties$347.0K1%

Related Comparisons